Quick Search 
Drugs of the Future
Register or sign in

Volume 39, Issue 5, May 2014, Pages 325-337
Antibacterial agent, Treatment of Clostridium difficile infection.
Kefauver, S.C.
Drugs Fut 2014, 39(5): 325
Summary | Full Text: PDF 
Reconstituted high-density lipoprotein (rHDL), Secondary treatment in acute coronary syndrome (ACS).
Haddley, K.
Drugs Fut 2014, 39(5): 333
Summary | Full Text: PDF 
Human anti-CD126 (IL-6R) monoclonal antibody, Treatment of rheumatoid arthritis.
Cole, P.
Drugs Fut 2014, 39(5): 339
Summary | Full Text: PDF 
 Biomarkers for metabolic syndrome – snapshot.
Gajdosik, Z., Castaner, R.
Drugs Fut 2014, 39(5): 345
Summary | Full Text: PDF 
 Pipeline on the move.
Navarro, D., Gonzalez Brao, M.M., Mila, M.
Drugs Fut 2014, 39(5): 349
Full Text: PDF 
 247th American Chemical Society National Meeting and Exposition (ACS), Dallas, Texas, USA – March 16-20, 2014.
McNamara, Y., Rosa, E.
Drugs Fut 2014, 39(5): 357
Summary | Full Text: PDF 
 115th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), Atlanta, Georgia, USA – March 19-22, 2014.
Garcia Capdevila, L.
Drugs Fut 2014, 39(5): 365
Summary | Full Text: PDF 
 41st Congress of the International Society of Oncology and Biomarkers/XIV International Symposium on Biology and Clinical Usefulness of Tumor Markers (ISOBM), Barcelona, Spain – March 15-18, 2014.
Fernandez, N.
Drugs Fut 2014, 39(5): 369
Summary | Full Text: PDF 
 Reducing attrition through early assessment of drug safety: Highlights from the Society of Medicines Research Symposium, held on March 13th, 2014 – National Heart & Lung Institute, Kensington, London, U.K.
Alderton, W., Holder, J., Lock, R., Pryde, D.
Drugs Fut 2014, 39(5): 373
Summary | Full Text: PDF 

© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy